Friday September 23, 2016

 

BREAKFAST
7:00 - 8:00 am


Non-Hodgkin's Lymphoma
8:00 – 9:25 AM 
Chair: Dr. Michael Crump

Introduction/Targeted Questions

Management of R/R FL in the Bendamustine Era

DLBCL – Frontline Therapy

Relapsed/Refractory DLBCL


Benign Disorders
9:25 am – 10:50 am
Chair: Dr. Tina Trinkaus

Introduction/Targeted Questions

Immune Cytopenias

Cancer-Associated VTE Management in 2016

Bloodbanking for the Clinical Haematologist – What You Need to Know


BREAK
10:50 - 11:05 am


Hodgkin's Lymphoma
11:05 am – 12:30 pm
Chair: Dr. John Kuruvilla

Introduction/Targeted Questions

Risk Adapted Therapy of HL – Update of Clinical Trials

Checkpoint Inhibition in Hodgkin’s Lymphoma

Staging and Response Assessment in Lymphoma


Lunch Symposiums:
 

12:30 - 2:15 pm
Initiating Treatment in Patients with Symptomatic Follicular Lymphoma – Why Timing Matters?


Speakers: Stefano Luminari, MD - Associate Professor of Oncology, University of Modena and Reggio Emilia, Italy
Douglas Stewart, MD, FRCPC - University of Calgary 

12:30 - 2:15 pm
Supportive Care Networking Lunch: The Use of Medical Marihuana for Patients in the Hematology Setting

Speakers: Ruth Turner RN. CCRP. CON(c).  - Princess Margaret Cancer Centre
Cindy Murray RN, NP-adult - Princess Margaret Cancer Centre
Rob Laister, MD, PhD - University Health Network


Plasma Cell Dyscrasias
2:15 – 3:15 pm
Chair: Dr. Peter Anglin

Introduction/Targeted Questions

New Drugs in R/R MM

Management of Plasmacytoma in 2016


BREAK
3:15 - 3:30 pm


Myeloproliferative Neoplasms
3:30 – 4:30 pm
Chair: Dr. Vikas Gupta

Introduction/Targeted Questions

The MPN World in the JAK 2 Inhibitor Era

A Clinician's Guide to MPN Diagnosis in 2016 


CONCLUDING REMARKS
4:30 pm - 4:45 pm 


CHC Cocktail Reception

5:00 - 6:30 pm

Please join the CHC faculty after the conference for beer and wine!  

Saturday September 24, 2016

 

BREAKFAST
7:00 - 8:00 am


Leukemia
8:00 – 9:00 am
Chair: Dr. Rena Buckstein

Introduction/Targeted Questions

Practical Issues Around Supportive Care for Acute Leukemia Patients

AML in 2016 – Approach to Therapy


BREAK
9:00 - 9:20 am


Chronic Lymphocytic Leukemia
9:20 – 10:45 am
Chair: Dr. Graeme Fraser

Introduction/Targeted Questions

Management of Ibrutinib Failure

Role of Allogeneic Transplant in 2016

Prognostic Factors and Treatment in Newly Diagnosed CLL


CONCLUDING REMARKS
10:45 - 11:00 am


Lunch Symposium

PNH and aHUS: Myths, Misconceptions, and Treatment Strategies for Patients
11:00 am - 12:45 pm

Speakers:  Ilene C. Weitz, MD-  University of Southern California (USC)
Christopher Patriquin, MD - University Health Network